Indian pharma industry to forge ahead, says report
The report maintained that the rise in gross domestic product, increasing population and the affluent middle class will largely contribute to the rise in Indian drug sales. However,
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.